Narcolepsy and hypersomnolence — structured clinical encounter

Station 1 — recognition

Asked for my first impression, I explain that a previously well child with three months of irresistible daytime sleepiness who loses muscle tone in the head and knees when he laughs, while staying fully aware, has cataplexy, and cataplexy is nearly specific for narcolepsy type 1. The rapid weight gain fits the hypothalamic involvement typical of paediatric narcolepsy, so I would treat this as narcolepsy type 1 until proven otherwise. [2] [9]

Station 2 — excluding the mimics and secondary causes

Asked what else I would consider, I state that I would confirm the episodes are true cataplexy and not syncope, atonic or gelastic seizures, drop attacks or pseudocataplexy, using the emotional trigger and preserved awareness to separate them. I would also take a targeted history to exclude the far commoner secondary sleepiness — insufficient sleep, obstructive sleep apnoea, delayed sleep phase, medication and depression — before committing to a primary diagnosis. [9] [1]

Station 3 — confirmation

To confirm, I would arrange overnight polysomnography to exclude another cause and confirm adequate sleep, followed by a multiple sleep latency test showing a mean sleep latency at or below eight minutes and two or more sleep-onset REM periods. Where doubt remains, a low cerebrospinal fluid orexin level, at or below 110 picograms per millilitre, confirms narcolepsy type 1. I would ensure he is off REM-suppressing drugs and interpret the results against his age. [3] [10]

Station 4 — management plan

Asked about treatment, I outline the non-drug foundation of sleep hygiene, planned short daytime naps, school accommodations, safety advice and psychological support, useful for every child. For the sleepiness I would use a wake-promoting agent such as modafinil first line, with pitolisant, methylphenidate or solriamfetol as alternatives. For the cataplexy I would use sodium oxybate, which also improves sleepiness and night sleep, or a REM-suppressing antidepressant, tapering rather than stopping it abruptly. [12] [13]

Station 5 — monitoring and the family conversation

Finally I describe monitoring the response against his sleepiness and function, watching cardiovascular effects and appetite with stimulants, tracking growth and weight given the risk of further gain, and screening for the mood problems that commonly accompany paediatric narcolepsy. I counsel the family that narcolepsy is a lifelong but treatable condition in which most children function well, that school accommodations matter, and that anticataplectic medication must never be stopped suddenly. [14] [1]